Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Svenja Happe

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
Brain Topography|October 10, 2002
Scalp topography of the spontaneous K-complex and of delta-waves in human sleepSvenja Happe, Peter Anderer, Georg Gruber, et al.
Health and Quality of Life Outcomes|September 22, 2011
Psychological distress of patients suffering from restless legs syndrome: a cross-sectional studyHanna Scholz, Heike Benes, Svenja Happe, et al.
Journal of Neurology|March 14, 2007
Association of daytime sleepiness with nigrostriatal dopaminergic degeneration in early Parkinson's diseaseSvenja Happe, Paul Christian Baier, Kathrin Helmschmied, et al.
Journal of the Neurological Sciences|June 2, 2007
Brain perfusion and VEP reactivity in occipital and parietal areas are associated to recovery from hypoxic vegetative stateHelmut Hildebrandt, Svenja Happe, Angelika Deutschmann, et al.
Journal of Neurology|January 13, 2005
Sleep microstructure and neurodegeneration as measured by [123I]beta-CIT SPECT in treated patients with Parkinson's diseaseSvenja Happe, Peter Anderer, Walter Pirker, et al.
Sleep Medicine|September 29, 2007
Homocysteine in restless legs syndromeCornelius G Bachmann, Nicolas Guth, Kathrin Helmschmied, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 25, 2004
Levodopa treatment does not affect low-dose apomorphine test in patients with Parkinson's diseaseSvenja Happe, Tobias Tings, Kathrin Helmschmied, et al.
Journal of Neurology|November 26, 2009
Fatigue, reduced sleep quality and restless legs syndrome in Charcot-Marie-Tooth disease: a web-based surveyMatthias Boentert, Rainer Dziewas, Anna Heidbreder, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|May 22, 2007
Growth hormone response to low-dose apomorphine in restless legs syndromeSvenja Happe, Cornelius G Bachmann, Kathrin Helmschmied, et al.
International Journal of Clinical Pharmacy|April 24, 2021
Enhancing medication therapy in Parkinson's disease by establishing an interprofessional network including pharmacistsOlaf Rose, Svenja Happe, Tessa Huchtemann, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Brain Topography|October 10, 2002
Scalp topography of the spontaneous K-complex and of delta-waves in human sleepSvenja Happe, Peter Anderer, Georg Gruber, et al.
Health and Quality of Life Outcomes|September 22, 2011
Psychological distress of patients suffering from restless legs syndrome: a cross-sectional studyHanna Scholz, Heike Benes, Svenja Happe, et al.
Journal of Neurology|March 14, 2007
Association of daytime sleepiness with nigrostriatal dopaminergic degeneration in early Parkinson's diseaseSvenja Happe, Paul Christian Baier, Kathrin Helmschmied, et al.
Journal of the Neurological Sciences|June 2, 2007
Brain perfusion and VEP reactivity in occipital and parietal areas are associated to recovery from hypoxic vegetative stateHelmut Hildebrandt, Svenja Happe, Angelika Deutschmann, et al.
Journal of Neurology|January 13, 2005
Sleep microstructure and neurodegeneration as measured by [123I]beta-CIT SPECT in treated patients with Parkinson's diseaseSvenja Happe, Peter Anderer, Walter Pirker, et al.
Sleep Medicine|September 29, 2007
Homocysteine in restless legs syndromeCornelius G Bachmann, Nicolas Guth, Kathrin Helmschmied, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 25, 2004
Levodopa treatment does not affect low-dose apomorphine test in patients with Parkinson's diseaseSvenja Happe, Tobias Tings, Kathrin Helmschmied, et al.
Journal of Neurology|November 26, 2009
Fatigue, reduced sleep quality and restless legs syndrome in Charcot-Marie-Tooth disease: a web-based surveyMatthias Boentert, Rainer Dziewas, Anna Heidbreder, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|May 22, 2007
Growth hormone response to low-dose apomorphine in restless legs syndromeSvenja Happe, Cornelius G Bachmann, Kathrin Helmschmied, et al.
International Journal of Clinical Pharmacy|April 24, 2021
Enhancing medication therapy in Parkinson's disease by establishing an interprofessional network including pharmacistsOlaf Rose, Svenja Happe, Tessa Huchtemann, et al.
Pageof 6